Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Clevidipine for Vasospasm After Subarachnoid Hemorrhage (SAH) (CLEVAS)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2013 by Henry Ford Health System.
Recruitment status was:  Not yet recruiting
Sponsor:
Information provided by (Responsible Party):
Panayiotis Varelas, Henry Ford Health System
ClinicalTrials.gov Identifier:
NCT02011321
First received: December 2, 2013
Last updated: December 10, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: September 2015
  Estimated Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)